Literature DB >> 22327012

Strain-related differences in antibody-mediated changes in gene expression are associated with differences in capsule and location of binding.

Erin E McClelland1, Arturo Casadevall.   

Abstract

We recently established that antibody (Ab)-binding can induce gene expression changes in a serotype A strain (H99) of the pathogenic yeast, Cryptococcus neoformans. That study showed that monoclonal antibodies (mAbs) differing in epitope specificity and protective efficacy elicited differences in gene expression. Because many mAbs bind to serotypes A and D strains differently, we now investigate the binding of one mAb to two strains representing these serotypes. Cells of the serotype A strain H99 and the serotype D strain 24067 were incubated with near saturating concentrations of the IgG1 capsule-binding mAb 18B7 or MOPC, an irrelevant mAb matched control. Comparative immunofluorescence analysis of mAb 18B7 binding revealed that it bound closer to the cell wall in H99 than 24067, where it was associated with decreased or increased cell diameter, respectively. A comparison of encapsulated cell compressibility showed that strain 24067 was more compressible than that of strain H99. RNA was extracted and used for gene expression analysis using the C. neoformans JEC21 genomic microarray. After 1h incubation with mAb 18B7, there were just 2 gene expression changes observed with strain 24067 or strain JEC21, unlike the 43 seen with strain H99. After 4h incubation with mAb 18B7, there were 14 and 140 gene expression changes observed with strain 24067 and JEC21, respectively. Thus, C. neoformans strains differ both in the response and the time of response to mAb binding and these differences may reflect differences in the location of Ab binding, Ab-mediated changes in cell diameter and compressibility of the capsular polysaccharide. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22327012      PMCID: PMC3482122          DOI: 10.1016/j.fgb.2012.01.006

Source DB:  PubMed          Journal:  Fungal Genet Biol        ISSN: 1087-1845            Impact factor:   3.495


  32 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Wsc1 and Mid2 are cell surface sensors for cell wall integrity signaling that act through Rom2, a guanine nucleotide exchange factor for Rho1.

Authors:  B Philip; D E Levin
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

3.  Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.

Authors:  J Mukherjee; L S Zuckier; M D Scharff; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

4.  Identification of Cryptococcus neoformans temperature-regulated genes with a genomic-DNA microarray.

Authors:  Peter R Kraus; Marie-Josée Boily; Steven S Giles; Jason E Stajich; Andria Allen; Gary M Cox; Fred S Dietrich; John R Perfect; Joseph Heitman
Journal:  Eukaryot Cell       Date:  2004-10

5.  Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans.

Authors:  S L Zebedee; R K Koduri; J Mukherjee; S Mukherjee; S Lee; D F Sauer; M D Scharff; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

6.  Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.

Authors:  J Mukherjee; L A Pirofski; M D Scharff; A Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

7.  Protective murine monoclonal antibodies to Cryptococcus neoformans.

Authors:  J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice.

Authors:  S Mukherjee; S Lee; J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

9.  Antibodies to Streptococcus pneumoniae capsular polysaccharide enhance pneumococcal quorum sensing.

Authors:  Masahide Yano; Shruti Gohil; J Robert Coleman; Catherine Manix; Liise-anne Pirofski
Journal:  mBio       Date:  2011-11-01       Impact factor: 7.867

10.  Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization.

Authors:  J Mukherjee; A Casadevall; M D Scharff
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more
  9 in total

1.  Methamphetamine Impairs IgG1-Mediated Phagocytosis and Killing of Cryptococcus neoformans by J774.16 Macrophage- and NR-9640 Microglia-Like Cells.

Authors:  Lilit Aslanyan; Hiu H Lee; Vaibhav V Ekhar; Raddy L Ramos; Luis R Martinez
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

2.  Antibody binding to Cryptococcus neoformans impairs budding by altering capsular mechanical properties.

Authors:  Radames J B Cordero; Bruno Pontes; Susana Frases; Antonio S Nakouzi; Leonardo Nimrichter; Marcio L Rodrigues; Nathan B Viana; Arturo Casadevall
Journal:  J Immunol       Date:  2012-12-10       Impact factor: 5.422

Review 3.  Physiological Differences in Cryptococcus neoformans Strains In Vitro versus In Vivo and Their Effects on Antifungal Susceptibility.

Authors:  Nina T Grossman; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

4.  Discovery and Characterization of a Peptoid with Antifungal Activity against Cryptococcus neoformans.

Authors:  Ashley E Corson; Scott A Armstrong; Matthew E Wright; Erin E McClelland; Kevin L Bicker
Journal:  ACS Med Chem Lett       Date:  2016-10-03       Impact factor: 4.345

5.  Fungal cell wall dynamics and infection site microenvironments: signal integration and infection outcome.

Authors:  Kelly M Shepardson; Robert A Cramer
Journal:  Curr Opin Microbiol       Date:  2013-04-15       Impact factor: 7.934

6.  Antibody Binding Alters the Characteristics and Contents of Extracellular Vesicles Released by Histoplasma capsulatum.

Authors:  Ludmila Matos Baltazar; Ernesto S Nakayasu; Tiago J P Sobreira; Hyungwon Choi; Arturo Casadevall; Leonardo Nimrichter; Joshua D Nosanchuk
Journal:  mSphere       Date:  2016-03-30       Impact factor: 4.389

7.  Novel Antifungal Activity for the Lectin Scytovirin: Inhibition of Cryptococcus neoformans and Cryptococcus gattii.

Authors:  Tyler H Jones; Erin E McClelland; Hana McFeeters; Robert L McFeeters
Journal:  Front Microbiol       Date:  2017-05-09       Impact factor: 5.640

8.  Antibody- Based Immunotherapy Combined With Antimycotic Drug TMP- SMX to Treat Infection With Paracoccidioides brasiliensis.

Authors:  Camila Boniche-Alfaro; Brenda Kischkel; Luciana Thomaz; Monique Maria Carvalho-Gomes; Leila M Lopes-Bezerra; Joshua Daniel Nosanchuk; Carlos Pelleschi Taborda
Journal:  Front Immunol       Date:  2021-10-19       Impact factor: 7.561

Review 9.  The Cryptococcus neoformans capsule: lessons from the use of optical tweezers and other biophysical tools.

Authors:  Bruno Pontes; Susana Frases
Journal:  Front Microbiol       Date:  2015-06-24       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.